Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2026 Filed Mar 12, 2026 20:16 UTC |
Gallman CariEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.10 par value | 912 | $0.00 | $0.00 |
DisclosureSEC source: 0001995058-26-000003 · wk-form4_1773346571.xml · nonDerivative · entry 1 Gallman Cari · CIK 0001995058 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 23,020 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · derivative · entry 15 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,020 Underlying: Common Stock, $0.10 par value · 23,020 shares Expires 2029-03-10 F12 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. F12 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
GrantMarket Share Units · Derivative | 15,347 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · derivative · entry 14 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,347 Underlying: Common Stock, $0.10 par value · 15,347 shares Expires 2029-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F11 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionPerformance Shares · Derivative | 4,822 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · derivative · entry 13 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,822 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. F5 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionMarket Share Units · Derivative | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · derivative · entry 12 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805 Underlying: Common Stock, $0.10 par value · 803 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionMarket Share Units · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · derivative · entry 11 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 811 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 1,256 | $60.13 | $75,523.28 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 9 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,094 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 8 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,350 F6 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 4,822 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 7 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 367 | $60.13 | $22,067.71 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 6 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,896 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 5 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,263 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 4 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 369 | $60.13 | $22,187.97 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 3 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,547 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 2 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,916 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:15 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0002005210-26-000002 · wk-form4_1773346512.xml · nonDerivative · entry 1 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
GrantPerformance Shares · Derivative | 9,796 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · derivative · entry 14 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,796 Underlying: Common Stock, $0.10 par value · 9,796 shares Expires 2029-03-10 F11 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. F11 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
GrantMarket Share Units · Derivative | 6,531 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · derivative · entry 13 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,531 Underlying: Common Stock, $0.10 par value · 6,531 shares Expires 2029-03-10 F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F10 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionPerformance Shares · Derivative | 6,304 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · derivative · entry 12 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 6,304 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. F5 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionMarket Share Units · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · derivative · entry 11 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052 Underlying: Common Stock, $0.10 par value · 1,050 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionMarket Share Units · Derivative | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · derivative · entry 10 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 838 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 912 | $60.13 | $54,838.56 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 9 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,210 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 3,095 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 8 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,122 F6 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 6,304 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 7 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 267 | $60.13 | $16,054.71 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 6 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,913 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 113 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 5 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,180 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 4 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 212 | $60.13 | $12,747.56 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 3 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,243 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 2 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,455 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0002005382-26-000002 · wk-form4_1773346616.xml · nonDerivative · entry 1 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
GrantPerformance Shares · Derivative | 7,547 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · derivative · entry 14 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,547 Underlying: Common Stock, $0.10 par value · 7,547 shares Expires 2029-03-10 F11 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. F11 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
GrantMarket Share Units · Derivative | 5,031 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · derivative · entry 13 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,031 Underlying: Common Stock, $0.10 par value · 5,031 shares Expires 2029-03-10 F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F10 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionPerformance Shares · Derivative | 4,612 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · derivative · entry 12 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,612 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. F5 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionMarket Share Units · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · derivative · entry 11 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 771 Underlying: Common Stock, $0.10 par value · 768 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionMarket Share Units · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · derivative · entry 10 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 811 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 849 | $60.13 | $51,050.37 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 9 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,362 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 2,264 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 8 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,211 F6 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 4,612 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 7 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 248 | $60.13 | $14,912.24 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 6 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,863 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 5 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,111 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 4 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Tax withholdingCommon Stock, $0.10 par value | 261 | $60.13 | $15,693.93 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 3 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,426 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
OtherCommon Stock, $0.10 par value | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 2 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,687 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:17 UTC |
Holzer Phil MSVP and Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0002012588-26-000002 · wk-form4_1773346669.xml · nonDerivative · entry 1 Holzer Phil M · CIK 0002012588 · SVP and Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
GrantPerformance Shares · Derivative | 9,796 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · derivative · entry 14 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,796 Underlying: Common Stock, $0.10 par value · 9,796 shares Expires 2029-03-10 F11 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. F11 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
GrantMarket Share Units · Derivative | 6,531 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · derivative · entry 13 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,531 Underlying: Common Stock, $0.10 par value · 6,531 shares Expires 2029-03-10 F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F10 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
Exercise / conversionPerformance Shares · Derivative | 4,495 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · derivative · entry 12 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,495 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each performance share unit converted into one share of common stock upon distribution in the first quarter of 2026. F5 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
Exercise / conversionMarket Share Units · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · derivative · entry 11 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock, $0.10 par value · 749 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
Exercise / conversionMarket Share Units · Derivative | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · derivative · entry 10 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 639 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
Tax withholdingCommon Stock, $0.10 par value | 828 | $60.13 | $49,787.64 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · nonDerivative · entry 9 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,917 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC |
Short Bartie WendyEVP, Corporate Affairs
|
OtherCommon Stock, $0.10 par value | 2,207 | $0.00 | $0.00 |
DisclosureSEC source: 0002070839-26-000002 · wk-form4_1773346920.xml · nonDerivative · entry 8 Short Bartie Wendy · CIK 0002070839 · EVP, Corporate Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,745 F6 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.